Pedro O. de Campos‐Lima

Author

Also Known As

P O De Campos-Lima, P O de Campos Lima, P O de Campos-Lima, P de Campos-Lima, P. O. de Campos Lima, P. O. de Campos-Lima, P.Otavio De Campos-Lima, PEDRO O. DE CAMPOS‐LIMA, Pedro O de Campos-Lima, Pedro O. De Campos-Lima

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Université Laval Karolinska Institutet Universidade Estadual de Campinas (UNICAMP)Centro Infantil Boldrini Centre hospitalier universitaire de Québec

About

Pedro O. de Campos‐Lima is an author at Université Laval specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	645
2	Natural Sciences	1	1	11
3	Allergy	1	1	25
4	Biochemistry	1	1	11
5	Biomedical Engineering	1	1	71

Pedro O. de Campos‐Lima

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 <sup>+</sup> Population Pedro O. de Campos‐Lima, Riccardo Gavioli, Qian-Jin Zhang, Science	1993	253
T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. Pedro O. de Campos‐Lima, Victor Levitsky, Jill Brooks, The Journal of Experimental Medicine ImmunologyPathologyVirus EvolutionAntigen ProcessingCd4 T Cell Responses	1994	161
Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4 Riccardo Gavioli, Michael G. Kurilla, Pedro O. de Campos‐Lima, Journal of Virology HistocompatibilityHla ImmunogeneticsImmunologyPathologyImmunodominance	1993	158
Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Riccardo Gavioli, Pedro O. de Campos‐Lima, Michael G. Kurilla, Proceedings of the National Academy of Sciences Hla ImmunogeneticsImmunologyPathologyImmunotherapyEpstein-barr Virus	1992	110
Epitope-dependent Selection of Highly Restricted or Diverse T Cell Receptor Repertoires in Response to Persistent Infection by Epstein-Barr Virus Pedro O. de Campos‐Lima, Victor Levitsky, Martha P. Imreh, The Journal of Experimental Medicine	1997	99
Efficient Human Hematopoietic Cell Transduction Using RD114- and GALV-Pseudotyped Retroviral Vectors Produced in Suspension and Serum-Free Media Karim Ghani, Xiuyan Wang, Pedro O. de Campos‐Lima, Human Gene Therapy Viral ReplicationSynthetic VirologyNeurovirologyMedicineHuman Retrovirus	2009	71
Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines. Vidar Wendel‐Hansen, Johan Sällström, Pedro O. de Campos‐Lima, PubMed	1994	66
The Clonal Composition of a Peptide-Specific Oligoclonal CTL Repertoire Selected in Response to Persistent EBV Infection Is Stable Over Time Victor Levitsky, Pedro O. de Campos‐Lima, Teresa Frisan, The Journal of Immunology Adaptive Immune SystemViral PathogenesisImmunologyPathologyImmunodominance	1998	63
Low Bioavailability and High Immunogenicity of a New Brand of E. coli l-Asparaginase with Active Host Contaminating Proteins Priscila Pini Zenatti, Natacha Azussa Migita, Nathália Moreno Cury, EBioMedicine	2018	47
Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy Sylvine Carrondo Cottin, Karim Ghani, Pedro O. de Campos‐Lima, Molecular Cancer	2010	38

Page 1